Area of research
Cancer Research · Pharmacology
Research interest
Research focused on Cancer research and TLR7, with related work in Amyotrophic lateral sclerosis, Metastasis, Downregulation and upregulation. Notable publications include 'PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way', 'MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability', and 'Cell-autonomous and non-cell-autonomous effect of TRIM72 on ALS disease progression'.